Ann: Company Update, page-13

You raise some valid questions however I think we all need to be realistic about how quickly shipments and sales of new medical products can actually take. The product was only launched in November and has barely had but several weeks (given the holiday season) to progress. The Italian shipment has been "invoiced" through its distributor whatever that means, and they are gradually branching out into other markets. A 12.5% fall in SP is a complete overreaction IMO to what I think is unsurprising but solid progress. The Neurotech story is unfolding positively at this stage and like all medical devices, will take substantially more time than most investors are willing too wait.